The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients

FEMS Immunology and Medical Microbiology

Volumn 65, Issue 2, 2012, Pages 236-244

  Rudkjøbing, Vibeke B ^a   Thomsen, Trine R ^a,b   Alhede, Morten ^c   Kragh, Kasper N ^c   Nielsen, Per H ^a   Johansen, Ulla R ^d   Givskov, Michael ^c   Høiby, Niels ^c,d   Bjarnsholt, Thomas ^c,d  

^a AALBORG UNIVERSITY   (Denmark)

^b DANISH TECHNOLOGICAL INSTITUTE   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

16S rRNA gene analysis; Achromobacter xylosoxidans; Biofilms; Chronic infection; Cystic fibrosis; Molecular diagnostic; Pseudomonas aeruginosa; Stenotrophomonas maltophilia

Indexed keywords

PEPTIDE NUCLEIC ACID;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM COLONY; BACTERIUM EXAMINATION; BURKHOLDERIA CEPACIA; CLINICAL ARTICLE; CYSTIC FIBROSIS; EXPLANT; FLUORESCENCE IN SITU HYBRIDIZATION; HAEMOPHILUS INFLUENZAE; HUMAN; LIMIT OF DETECTION; LUNG INFECTION; MICROBIAL DIVERSITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA GENE; SPUTUM EXAMINATION; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BIODIVERSITY; CYSTIC FIBROSIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG; PNEUMONIA, BACTERIAL; REAL-TIME POLYMERASE CHAIN REACTION; SPUTUM;

EID: 84862648883     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00925.x     Document Type: Article

References (34)

1. Anuj SN, Whiley DM, Kidd TJ, Bell SC, Wainwright CE, Nissen MD & Sloots TP (2009) Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. Diagn Microbiol Infect Dis 63: 127-131.
2. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N & Givskov M (2008) Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16: 2-10.
3. Bjarnsholt T, Jensen P, Fiandaca M, Pedersen J, Hansen C, Andersen C, Pressler T, Givskov M & Høiby N (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44: 547-558.
4. Bjarnsholt T, Nielsen X, Johansen U, Nørgaard L & Høiby N (2011) Methods to classify bacterial pathogens in cystic fibrosis. Cystic Fibrosis: Diagnosis and Protocols, Vol. II: Methods and Resources to Understand Cystic Fibrosis, vol. 742 (Amaral M & Kunzelmann K, eds), pp. 143-171. Humana Press, Totowa, NJ.
5. Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J. 23: 146-158.
6. Braun AT & Merlo CA (2011) Cystic fibrosis lung transplantation. Curr Opin Pulm Med. 17: 467-472.
7. Burmølle M, Thomsen TR, Fazli M et al. (2010) Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol 59: 324-336.
8. Conese M, Copreni E, Gioia SD, Rinaldis PD & Fumarulo R (2003) Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease. J Cyst Fibros 2: 129-135.
9. Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
10. Deschaght P, De Baere T, Van Simaey L, Van daele S, De Baets F, De Vos D, Pirnay J-P & Vaneechoutte M (2009) Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients. BMC Microbiol 9: 244.
11. Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA & Wolcott RD (2008) Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8: 43.
12. Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen B, Andersen AS, Krogfelt KA, Givskov M & Tolker-Nielsen T (2009) Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol 47: 4084-4089.
13. Gilligan PH (1991) Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4: 35-51.
14. Guss AM, Roeselers G, Newton ILG, Young CR, Klepac-Ceraj V, Lory S & Cavanaugh CM (2011) Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J 5: 20-29.
15. Hansen CR, Pressler T, Nielsen KG, Jensen PØ, Bjarnsholt T & Høiby N (2010) Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 9: 51-58.
16. Harrison F (2007) Microbial ecology of the cystic fibrosis lung. Microbiology 153: 917-923.
17. Hein I, Lehner A, Rieck P, Klein K, Brandl E & Wagner M (2001) Comparison of different approaches to quantify Staphylococcus aureus cells by real-time quantitative PCR and application of this technique for examination of cheese. Appl Environ Microbiol 67: 3122-3126.
18. Høiby N, Frederiksen B & Pressler T (2005) Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 4: 49-54.
19. Jacobs JL & Dinman JD (2004) Systematic analysis of bicistronic reporter assay data. Nucleic Acids Res 32: e160.
20. Jaffe RI, Lane JD & Bates CW (2001) Real-time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR). J Clin Lab Anal 15: 131-137.
21. Jørgensen IM, Johansen HK, Frederiksen B, Pressler T, Hansen A, Vandamme P, Høiby N & Koch C (2003) Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol 36: 439-446.
22. Kirketerp-Møller K, Jensen PØ, Fazli M, Madsen KG, Pedersen J, Moser C, Tolker-Nielsen T, Høiby N, Givskov M & Bjarnsholt T (2008) Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 46: 2717-2722.
23. Koch R (1884) Die Aetiologie der Tuberkulose. Berliner Klinische Wochenschrift 2: 1-88.
24. Moser C et al. (2009) Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis. APMIS 117: 95-107.
25. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Kehagia V, Connett GJ & Bruce KD (2006) Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 44: 2601-2604.
26. Rogers GB, Stressmann FA, Walker AW, Carroll MP & Bruce KD (2010) Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. Expert Rev Mol Diagn 10: 187-196.
27. Rønne Hansen C, Pressler T, Høiby N & Gormsen M (2006) Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J Cyst Fibros 5: 245-251.
28. Rudkjøbing VB, Thomsen TR, Alhede M, Kragh KN, Nielsen PH, Johansen UR, Givskov M, Høiby N & Bjarnsholt T (2011) True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis. J Clin Microbiol 49: 4352-4355.
29. Saiman L (2004) Microbiology of early CF lung disease. Paediatr Respir Rev 5: S367-S369.
30. Skovhus TL, Ramsing NB, Holmstrom C, Kjelleberg S & Dahllof I (2004) Real-time quantitative PCR for assessment of abundance of Pseudoalteromonas species in marine samples. Appl Environ Microbiol 70: 2373-2382.
31. Stender H (2003) PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases. Expert Rev Mol Diagn 3: 649-655.
32. Stressmann FA et al. (2011) Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers. J Clin Microbiol 49: 281-291.
33. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, Rohwer F & Conrad D (2011) Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J. doi:10.1038/ismej.2011.104
34. Worlitzsch D, Rintelen C, Böhm K, Wollschläger B, Merkel N, Borneff-Lipp M & Döring G (2009) Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect 15: 454-460.